DK2062914T3 - Somatostatin-dopamin-chimære analoger - Google Patents

Somatostatin-dopamin-chimære analoger

Info

Publication number: DK2062914T3
Authority: DK; Denmark
Prior art keywords: somatostatin; dopamine chimeric; chimeric analogs; analogs; dopamine
Prior art date: 2001-06-08

Application number

DK08171319.0T

Other languages

English (en)

Inventor

Michael D Culler

Zheng Xin Dong

Sun H Kim

Jacques-Pierre Moreau

Original Assignee

Ipsen Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-08

Filing date

2002-06-07

Publication date

2014-07-14

2002-06-07 Application filed by Ipsen Pharma filed Critical Ipsen Pharma

2014-07-14 Application granted granted Critical

2014-07-14 Publication of DK2062914T3 publication Critical patent/DK2062914T3/da

Links

229960003638 dopamine Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
- C07D457/12—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Immunology (AREA)
Hematology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Obesity (AREA)
Zoology (AREA)
Physical Education & Sports Medicine (AREA)
Toxicology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Biomedical Technology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Nutrition Science (AREA)
Reproductive Health (AREA)

DK08171319.0T 2001-06-08 2002-06-07 Somatostatin-dopamin-chimære analoger DK2062914T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US29705901P	2001-06-08	2001-06-08
EP02734699A EP1401863B1 (en)	2001-06-08	2002-06-07	Somatostatin-dopamine chimeric analogs

Publications (1)

Publication Number	Publication Date
DK2062914T3 true DK2062914T3 (da)	2014-07-14

Family

ID=23144680

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK02734699T DK1401863T3 (da)	2001-06-08	2002-06-07	Kimære somatostatin-dopamin-analoge
DK08171319.0T DK2062914T3 (da)	2001-06-08	2002-06-07	Somatostatin-dopamin-chimære analoger

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK02734699T DK1401863T3 (da)	2001-06-08	2002-06-07	Kimære somatostatin-dopamin-analoge

Country Status (24)

Country	Link
US (4)	US7579435B2 (da)
EP (2)	EP2062914B1 (da)
JP (2)	JP3996897B2 (da)
KR (3)	KR100743212B1 (da)
CN (2)	CN1514843A (da)
AR (1)	AR037226A1 (da)
AT (1)	ATE424414T1 (da)
AU (1)	AU2002305845B2 (da)
BR (1)	BR0210915A (da)
CA (1)	CA2449634C (da)
CZ (1)	CZ305160B6 (da)
DE (1)	DE60231403D1 (da)
DK (2)	DK1401863T3 (da)
ES (2)	ES2483722T3 (da)
HU (1)	HUP0400245A3 (da)
IL (2)	IL158922A0 (da)
MX (1)	MXPA03011321A (da)
NO (2)	NO332042B1 (da)
NZ (1)	NZ530007A (da)
PL (1)	PL216217B1 (da)
PT (2)	PT1401863E (da)
RU (1)	RU2277539C2 (da)
TW (1)	TWI318214B (da)
WO (1)	WO2002100888A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR0212897A (pt) *	2001-09-21	2004-08-24	Univ Tulane	Conjugados de análogos de somatostatina ou bombesina diagnóstica ou terapêutica e usos dos mesmos
AU2008200694B2 (en) *	2003-04-11	2011-04-14	Ipsen Pharma S.A.S.	Method of treating acromegaly, hyperprolactinemia, portal hypertension and gastrointestinal bleeding with somatostatin-dopamine chimeric analogs
AU2004229437B2 (en)	2003-04-11	2007-12-06	Ipsen Pharma S.A.S.	Somatostatin-dopamine chimeric analogs
NZ564694A (en) *	2003-04-22	2009-11-27	Sod Conseils Rech Applic	Peptide vectors
DE10325813B4 (de) *	2003-06-06	2007-12-20	Universitätsklinikum Freiburg	Prophylaxe und/oder Therapie bei der portalen Hypertonie
CA2602368A1 (en) *	2005-04-28	2006-11-02	Ferring B.V.	Use of novel compounds for ibd treatment
US9098855B2 (en) *	2006-05-23	2015-08-04	Intelligent Clearing Network, Inc.	Intelligent clearing network
WO2009139855A2 (en) *	2008-05-14	2009-11-19	Ipsen Pharma S.A.S.	Pharmaceutical compositions of somatostatin-dopamine conjugates
FR2949469A1 (fr) *	2009-08-25	2011-03-04	Sanofi Aventis	Derives anticancereux, leur preparation et leur application en therapeutique
WO2011104627A1 (en) *	2010-02-24	2011-09-01	Ipsen Pharma S.A.S.	Metabolites of dop2-d-lys(dop2)-cyclo[cys-tyr-d-trp-lys-abu-cys]-thr-nh2
CN103547591A (zh) *	2011-04-21	2014-01-29	瑟瑞技术公司	生长激素释放因子(grf)类似物及其用途
UA115542C2 (uk)	2011-12-23	2017-11-27	Іпсен Мануфекчерінг Айрленд Лімітед	Процес синтезу терапевтичних пептидів
US9620430B2 (en)	2012-01-23	2017-04-11	Taiwan Semiconductor Manufacturing Company, Ltd.	Sawing underfill in packaging processes
CN104768565B (zh)	2012-11-01	2017-04-26	益普生制药股份有限公司	促生长素抑制素类似物及其二聚体
TWI523863B (zh)	2012-11-01	2016-03-01	艾普森藥品公司	體抑素－多巴胺嵌合體類似物
DK2925341T3 (da) *	2012-12-03	2018-05-07	Univ Oklahoma	Peptidforbindelser og fremgangsmåder til fremstilling og anvendelse deraf
US9096679B2 (en)	2012-12-03	2015-08-04	The Board Of Regents Of The University Of Oklahoma	Peptide compounds and methods of production and use thereof
US20200157159A1 (en)	2013-04-16	2020-05-21	The Board Of Regents Of The University Of Oklahoma	Peptide compounds and compositions thereof
EP3166967B1 (en)	2014-09-14	2023-03-08	Tel Hashomer Medical Research Infrastructure and Services Ltd.	Synthetic somatostatin receptor ligands
JP6856532B2 (ja)	2015-01-20	2021-04-07	エックスオーシーファーマシューティカルズインコーポレイテッドＸｏｃＰｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ	エルゴリン化合物およびその使用
JP2018502889A (ja)	2015-01-20	2018-02-01	エックスオーシーファーマシューティカルズインコーポレイテッドＸｏｃＰｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ	イソエルゴリン化合物およびその使用
EP3630758A1 (en)	2017-06-01	2020-04-08	Xoc Pharmaceuticals, Inc	Ergoline derivatives for use in medicine
WO2023225043A1 (en) *	2022-05-18	2023-11-23	Kuleon Llc	Tricyclic and tetracyclic serotonin receptor modulators and methods of making and using the same

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2589978A (en) *		1952-03-18		Lysergyl and isolysergyl glycines
DE140044C (da)
US2619488A (en) *		1952-11-25		Method of preparing d
AT258479B (de) *	1961-05-29	1967-11-27	Farmaceutici Italia	Verfahren zur Herstellung von neuen Verbindungen aus der Klasse des D-6-Methyl- (und -1,6-Dimethyl)-8-amino-methyl-ergolins I
NL128196C (da)	1961-05-29
US3966941A (en)	1970-09-23	1976-06-29	Spofa United Pharmaceutical Works	Composition for preventing lactation or pregnancy in mammals and the method for using the same
US3901894A (en) *	1974-06-06	1975-08-26	Lilly Co Eli	8-thiomethylergolines
US4291022A (en)	1975-03-11	1981-09-22	Sandoz Ltd.	Organic compounds
HU172479B (hu)	1976-03-09	1978-09-28	Gyogyszerkutato Intezet	Sposob poluchenija novykh soedinenij s ehrgolenovymi i
US4133782A (en)	1976-06-07	1979-01-09	The Salk Institute For Biological Studies	Somatostatin analogs with dissociated biological activities
GB1580448A (en) *	1976-12-06	1980-12-03	Farmaceutici Italia	8 -acetyl-6-methyl-ergoline i derivatives
US4190575A (en)	1977-12-27	1980-02-26	American Home Products Corporation	Polypeptides related to somatostatin
IT1105131B (it)	1977-06-08	1985-10-28	Merck & Co Inc	Peptidi analoghi della somatostatina dotati di piu' lunga e maggiore attivita' biologica e relativo procedimento di protezione
US4357259A (en)	1977-08-01	1982-11-02	Northwestern University	Method of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres
US4211693A (en)	1977-09-20	1980-07-08	The Salk Institute For Biological Studies	Peptides with para-substituted phenylalanine
LU78191A1 (de)	1977-09-28	1979-05-25	Ciba Geigy Ag	Verfahren zur herstellung von neuen cyclopeptiden
US4166182A (en) *	1978-02-08	1979-08-28	Eli Lilly And Company	6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
CA1107273A (en)	1978-05-19	1981-08-18	Chester A. Meyers	Somatostatin analogs having a substituted tryptophyl residue in position eight
JPS5819669B2 (ja)	1978-10-28	1983-04-19	白井松新薬株式会社	新規生理活性ペプチド化合物及びその製造法
DD140044A1 (de) *	1978-11-08	1980-02-06	Guenter Losse	Verfahren zur herstellung von lysergyl-enkephalin-derivaten
US4215039A (en)	1979-02-15	1980-07-29	American Home Products Corporation	Somatostatin analogues
US4190648A (en)	1979-03-13	1980-02-26	Merck & Co., Inc.	Peptides having somatostatin activity
US4316890A (en)	1979-03-16	1982-02-23	Ciba-Geigy Corporation	Peptides and processes for the manufacture thereof
US4209426A (en)	1979-05-29	1980-06-24	American Home Products Corporation	Polypeptides related to somatostatin
US4328214A (en)	1979-07-04	1982-05-04	Ciba-Geigy Corporation	Cyclopeptides and pharmaceutical preparations thereof and also processes for their manufacture
US4235886A (en)	1979-10-31	1980-11-25	Merck & Co., Inc.	Cyclic hexapeptide somatostatin analogs
US4310518A (en)	1979-10-31	1982-01-12	Merck & Co., Inc.	Cyclic hexapeptide somatostatin analogs
EP0029579B1 (en)	1979-11-27	1983-02-16	Sandoz Ag	Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
US4369179A (en)	1979-12-14	1983-01-18	Ciba-Geigy Corporation	Acylpeptides
EP0031303A3 (de)	1979-12-21	1981-11-04	Ciba-Geigy Ag	Cyclooctapeptide und pharmazeutische Präparate davon, sowie Verfahren zur Herstellung derselben und ihre Anwendung
DE3001752A1 (de) *	1980-01-16	1981-07-30	Schering Ag Berlin Und Bergkamen, 1000 Berlin	Verfahren zur herstellung von 8(alpha)-substituierten 6-methylergolinen
US4282143A (en)	1980-06-13	1981-08-04	American Home Products Corporation	Octapeptides lowering growth hormone
US4526892A (en) *	1981-03-03	1985-07-02	Farmitalia Carlo Erba, S.P.A.	Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas
DK81082A (da)	1981-03-06	1982-09-07	Sandoz Ag	Fremgangsmaade til fremstilling af polypeptider
US4360516A (en)	1981-04-13	1982-11-23	Merck & Co., Inc.	Modified D-retro cyclic hexapeptide somatostatin analogs
GB2103603B (en)	1981-08-11	1985-04-11	Erba Farmitalia	Ergoline derivatives
GB2112382B (en)	1981-11-06	1985-03-06	Erba Farmitalia	Ergoline derivatives
ATE14226T1 (de)	1981-12-24	1985-07-15	Ciba Geigy Ag	Cyclische octapeptide und pharmazeutische praeparate davon, sowie verfahren zur herstellung derselben und ihre anwendung.
FR2522655B1 (fr)	1982-03-05	1987-03-06	Sanofi Sa	Analogues de la somatostatine possedant une liaison du type hydrazide et medicaments en contenant
PH21123A (en)	1983-04-28	1987-07-27	Erba Farmitalia	Ergoline derivatives
US4486415A (en)	1983-08-15	1984-12-04	Merck & Co., Inc.	Cyclic hexapeptide somatostatin analogs
US4485101A (en)	1983-10-11	1984-11-27	Administrators Of The Tulane Educational Fund	Peptides
US4522813A (en)	1983-10-27	1985-06-11	Merck & Co., Inc.	Cyclic hexapeptide somatostatin analogs
US4684620A (en)	1984-09-04	1987-08-04	Gibson-Stephens Neuropharmaceuticals, Inc.	Cyclic polypeptides having mu-receptor specificity
HUT42101A (en)	1985-01-07	1987-06-29	Sandoz Ag	Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
US4725577A (en)	1985-04-25	1988-02-16	Administrators Of The Tulane Educational Fund	Biologically active lysine containing octapeptides
US4650787A (en)	1985-04-25	1987-03-17	Schally Andrew Victor	Biologically active octapeptides
US4585755A (en)	1985-04-29	1986-04-29	Merck & Co., Inc.	Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4904642A (en)	1985-09-12	1990-02-27	The Administrators Of The Tulane Educational Fund	Therapeutic somatostatin analogs
US4853371A (en)	1986-06-17	1989-08-01	The Administrators Of The Tulane Educational Fund	Therapeutic somatostatin analogs
NL194729C (nl)	1986-10-13	2003-01-07	Novartis Ag	Werkwijze voor de bereiding van peptidealcoholen via vaste fase.
US4871717A (en)	1987-01-07	1989-10-03	Administrators Of The Tulane Educational Fund	Peptides
DE3845000C2 (de)	1987-07-10	1998-11-19	Novartis Ag	Anwendung von Octreotid zur Behandlung von Brustkrebs
JPH03502328A (ja)	1988-02-01	1991-05-30	ジ・アップジョン・カンパニー	極性末端基類を有するレニン抑制ペプチド類
GB8813339D0 (en)	1988-06-06	1988-07-13	Sandoz Ltd	Improvements in/relating to organic compounds
ZA895838B (en)	1988-08-18	1991-03-27	Syntex Inc	Pharmaceutical compounds
CA2012115C (en)	1989-03-15	2001-07-03	Biomeasure, Inc.	Iodinated somatostatins
JP2882679B2 (ja)	1989-04-26	1999-04-12	ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド	線状ソマトスタチン類似体
US5621133A (en) *	1989-05-31	1997-04-15	Deninno; Michael P.	Dopamine agonists
HU203549B (en)	1989-06-27	1991-08-28	Richter Gedeon Vegyeszet	New stereoselektive hydrogenating process for producing dihydro-lisergol
ES2091907T3 (es)	1989-12-08	1996-11-16	Univ Tulane	Analogos octapeptidos de somatostina con una threonina en la sexta posicion.
US5411966A (en)	1990-01-15	1995-05-02	Schering Aktiengesellschaft	2, 13-disubstituted ergolines, their production and use in pharmaceutical agents
AU644625B2 (en)	1990-01-25	1993-12-16	Farmitalia Carlo Erba S.R.L.	Process for preparing ergoline derivatives
US5043341A (en)	1990-04-11	1991-08-27	Eli Lilly And Company	N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides
IT1240643B (it)	1990-05-11	1993-12-17	Mediolanum Farmaceutici Spa	Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano
CA2087019A1 (en) *	1990-07-10	1992-01-11	Richard L. Weinshank	Nucleic acid sequences encoding a human dopamine d1 receptor
HU207104B (en)	1991-01-25	1993-03-01	Biosignal Kutato Fejlesztoe Kf	Process for producing new somatostatin analogs inhibiting tumour growth and pharmaceutical compositions comprising such compounds
EP0658229A4 (en)	1992-08-20	1997-10-08	Ind Progress Inc	PROCESS FOR PRODUCING PAPER UNDER ACIDAL ALKALINE CONDITIONS.
DK0628042T3 (da)	1992-12-24	2001-11-12	Pharmacia & Upjohn Spa	Serotoninerge ergolinderivater
FR2699923B1 (fr)	1992-12-28	1995-03-17	Great Lakes Chemical France	Copolymères d'esters gras insaturés, leur utilisation comme additif de viscosité et huile lubrifiante contenant lesdits copolymères.
CA2154487A1 (en)	1993-01-21	1994-08-04	Nicholas S. Hill	Vaccines and methods for preventing and treating fescue toxicosis in herbivores
GB9417873D0 (en) *	1994-09-06	1994-10-26	Sandoz Ltd	Organic compounds
GB9513224D0 (en) *	1995-06-29	1995-09-06	Sandoz Ltd	Organic compounds
MY147327A (en)	1995-06-29	2012-11-30	Novartis Ag	Somatostatin peptides
AU2582197A (en) *	1996-03-15	1997-10-01	Start Technology Partnership	Methods and compositions for diagnosis and treatment of pathological conditions related to abnormal dopamine receptor expression
US5925618A (en) *	1997-03-06	1999-07-20	American Cyanamid Company	Peptides useful as somatostatin antagonists
GB9711043D0 (en) *	1997-05-29	1997-07-23	Ciba Geigy Ag	Organic compounds
DE19832191A1 (de)	1998-07-17	2000-01-27	Knoell Hans Forschung Ev	Neuartige Ergolinamin-Derivate und ihre Verwendung

2002
- 2002-06-07 JP JP2003503654A patent/JP3996897B2/ja not_active Expired - Fee Related
- 2002-06-07 PT PT02734699T patent/PT1401863E/pt unknown
- 2002-06-07 DE DE60231403T patent/DE60231403D1/de not_active Expired - Lifetime
- 2002-06-07 RU RU2004100109/04A patent/RU2277539C2/ru not_active IP Right Cessation
- 2002-06-07 ES ES08171319.0T patent/ES2483722T3/es not_active Expired - Lifetime
- 2002-06-07 DK DK02734699T patent/DK1401863T3/da active
- 2002-06-07 AU AU2002305845A patent/AU2002305845B2/en not_active Ceased
- 2002-06-07 KR KR1020057022692A patent/KR100743212B1/ko not_active Expired - Fee Related
- 2002-06-07 WO PCT/US2002/017859 patent/WO2002100888A1/en not_active Ceased
- 2002-06-07 PT PT81713190T patent/PT2062914E/pt unknown
- 2002-06-07 EP EP08171319.0A patent/EP2062914B1/en not_active Expired - Lifetime
- 2002-06-07 ES ES02734699T patent/ES2325880T3/es not_active Expired - Lifetime
- 2002-06-07 HU HU0400245A patent/HUP0400245A3/hu unknown
- 2002-06-07 NZ NZ530007A patent/NZ530007A/en not_active IP Right Cessation
- 2002-06-07 CZ CZ2003-3122A patent/CZ305160B6/cs not_active IP Right Cessation
- 2002-06-07 CN CNA028114647A patent/CN1514843A/zh active Pending
- 2002-06-07 TW TW091112381A patent/TWI318214B/zh not_active IP Right Cessation
- 2002-06-07 US US10/479,771 patent/US7579435B2/en not_active Expired - Fee Related
- 2002-06-07 MX MXPA03011321A patent/MXPA03011321A/es active IP Right Grant
- 2002-06-07 AT AT02734699T patent/ATE424414T1/de active
- 2002-06-07 BR BR0210915-8A patent/BR0210915A/pt not_active IP Right Cessation
- 2002-06-07 EP EP02734699A patent/EP1401863B1/en not_active Expired - Lifetime
- 2002-06-07 IL IL15892202A patent/IL158922A0/xx unknown
- 2002-06-07 KR KR1020037016005A patent/KR100620435B1/ko not_active Expired - Fee Related
- 2002-06-07 DK DK08171319.0T patent/DK2062914T3/da active
- 2002-06-07 KR KR1020067014785A patent/KR100754917B1/ko not_active Expired - Fee Related
- 2002-06-07 CA CA2449634A patent/CA2449634C/en not_active Expired - Fee Related
- 2002-06-07 PL PL364457A patent/PL216217B1/pl unknown
- 2002-06-07 CN CNA2008101781440A patent/CN101481405A/zh active Pending
- 2002-06-10 AR ARP020102180A patent/AR037226A1/es unknown
2003
- 2003-12-02 NO NO20035358A patent/NO332042B1/no not_active IP Right Cessation
2006
- 2006-05-15 US US11/434,273 patent/US7572883B2/en not_active Expired - Fee Related
2007
- 2007-02-26 JP JP2007044989A patent/JP4181203B2/ja not_active Expired - Fee Related
2009
- 2009-06-22 US US12/456,715 patent/US8178651B2/en not_active Expired - Fee Related
- 2009-10-01 IL IL201310A patent/IL201310A/en not_active IP Right Cessation
- 2009-10-07 US US12/587,452 patent/US8324386B2/en not_active Expired - Fee Related
2011
- 2011-08-26 NO NO20111165A patent/NO338459B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2449634C (en)	2011-08-02
AR037226A1 (es)	2004-11-03
DE60231403D1 (de)	2009-04-16
PT2062914E (pt)	2014-07-18
JP4181203B2 (ja)	2008-11-12
NO20111165L (no)	2004-01-28
IL158922A0 (en)	2004-05-12
WO2002100888A1 (en)	2002-12-19
JP3996897B2 (ja)	2007-10-24
RU2004100109A (ru)	2005-06-27
HUP0400245A3 (en)	2012-09-28
AU2002305845B2 (en)	2006-03-30
CZ305160B6 (cs)	2015-05-27
KR20040004699A (ko)	2004-01-13
US20100179304A1 (en)	2010-07-15
US20090275501A1 (en)	2009-11-05
NZ530007A (en)	2006-02-24
CN1514843A (zh)	2004-07-21
KR20050118740A (ko)	2005-12-19
KR100620435B1 (ko)	2006-09-12
PL216217B1 (pl)	2014-03-31
MXPA03011321A (es)	2004-12-06
EP2062914B1 (en)	2014-05-07
HK1060360A1 (en)	2004-08-06
ATE424414T1 (de)	2009-03-15
EP2062914A3 (en)	2009-08-05
DK1401863T3 (da)	2009-05-25
PT1401863E (pt)	2009-07-23
US7579435B2 (en)	2009-08-25
US8324386B2 (en)	2012-12-04
NO20035358D0 (no)	2003-12-02
RU2277539C2 (ru)	2006-06-10
ES2325880T3 (es)	2009-09-23
TWI318214B (en)	2009-12-11
KR20060090842A (ko)	2006-08-16
EP1401863A4 (en)	2006-04-26
IL201310A (en)	2012-06-28
CZ20033122A3 (cs)	2004-05-12
HUP0400245A2 (hu)	2004-08-30
EP1401863B1 (en)	2009-03-04
US20060211607A1 (en)	2006-09-21
ES2483722T3 (es)	2014-08-07
NO332042B1 (no)	2012-06-11
US7572883B2 (en)	2009-08-11
BR0210915A (pt)	2004-06-08
CA2449634A1 (en)	2002-12-19
JP2007224033A (ja)	2007-09-06
US20040209798A1 (en)	2004-10-21
EP1401863A1 (en)	2004-03-31
JP2005503357A (ja)	2005-02-03
PL364457A1 (en)	2004-12-13
KR100754917B1 (ko)	2007-09-04
CN101481405A (zh)	2009-07-15
KR100743212B1 (ko)	2007-07-26
US8178651B2 (en)	2012-05-15
NO338459B1 (no)	2016-08-15
EP2062914A2 (en)	2009-05-27

Publication	Publication Date	Title
DK2062914T3 (da)	2014-07-14	Somatostatin-dopamin-chimære analoger
DE60227853D1 (de)	2008-09-04	Substituierte Pyridinylamine
IS6971A (is)	2003-09-29	Ný efnasambönd
DE50206892D1 (de)	2006-06-29	Substituierte imidazotriazinone
NO20054371D0 (no)	2005-09-21	Somatostatin-dopamin kimaere analoger
DK1373228T3 (da)	2008-08-04	Substituerede fluoralkoxyphenylsulfonylurinstoffer
DK1406858T3 (da)	2009-11-23	Substituerede 4-aminocyklohexanoler
NO20041066L (no)	2004-06-14	Hydroksyeikosensyre-analoger
DE60216967D1 (de)	2007-02-01	Substituierte cyclohexanderivate
SE0103271D0 (sv)	2001-09-28	Novel compounds
SE0200704D0 (sv)	2002-03-11	Novel compounds
SE0103820D0 (sv)	2001-11-15	Novel compounds
SE0102156D0 (sv)	2001-06-14	Novel compounds
SE0101933D0 (sv)	2001-06-01	Novel compounds
SE0102807D0 (sv)	2001-08-22	Novel compounds
SE0102618D0 (sv)	2001-07-25	Novel compounds
SE0104474D0 (sv)	2001-12-18	Novel Compounds
SE0102403D0 (sv)	2001-07-04	Novel compounds
SE0104472D0 (sv)	2001-12-14	Novel Compounds
SE0102053D0 (sv)	2001-06-08	Novel compounds
SE0100641D0 (sv)	2001-02-26	Novel compounds
SE0100966D0 (sv)	2001-03-19	Novel compounds
SE0101321D0 (sv)	2001-04-12	Novel compounds
SE0101617D0 (sv)	2001-05-08	Novel compounds
SE0104141D0 (sv)	2001-12-07	Novel compounds